IceCure faces certified class action over alleged discounted private placement

• IceCure Medical faces a certified class action in Tel Aviv District Court tied to a March 7, 2021 private placement.
• The court certified two plaintiff classes on May 5, 2026, naming the shareholder plaintiff as representative.
• The plaintiff filed the class action claim on June 25, 2026, alleging discounted pricing, missing material information, flawed approvals.
• IceCure plans a reconsideration motion in the court’s Economic Department by July 5, 2026, seeking to overturn certification.
• The company expects to pursue mediation, then request a stay of proceedings once the reconsideration motion is filed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IceCure Medical Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-072644), on June 26, 2026, and is solely responsible for the information contained therein.